Sage Therapeutic Com (NQ: SAGE )
8.410
+0.220
(+2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Sage Therapeutic Com
![](https://cdn.benzinga.com/files/images/story/2022/08/02/biotech4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7522.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220801005685/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20220801005269/en/1442032/5/Sage_Logo.jpg)
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_19282.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_13421.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4922.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7504.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6011.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220718005799/en/1442032/5/Sage_Logo.jpg)
![](https://mms.businesswire.com/media/20220601006140/en/1442032/5/Sage_Logo.jpg)
![](https://www.investors.com/wp-content/uploads/2022/02/Stock-sagetherapeutics-02-shutt.jpg)
![](https://mms.businesswire.com/media/20220531006081/en/1472550/5/Biogen_Logo_Standard.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_10264.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220503006360/en/1442032/5/Sage_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/03/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220502005915/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/02/aapharma_7.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/02/biotech7.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4854.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220429005707/en/1438772/5/Biogen_Logo_Standard.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_3645.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220413005785/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/red-blood-cell-gc6575ac93_1920_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/biotech6_1.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://mms.businesswire.com/media/20220331006048/en/736779/5/Sage_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_5926.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220321005602/en/736779/5/Sage_logo.jpg)
Sage Therapeutics to Present at 2022 Stifel CNS Days
March 22, 2022
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.